NASDAQ:REGN

Regeneron Pharmaceuticals Stock Insider Trading

etoro logo Buy REGN
*Your capital is at risk
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026

Regeneron Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -20.32. In total, the insiders bought 60.13K and sold 34.14K REGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-20.32
Buy 60.13K shares
Sell 34.14K shares
29% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Dec 09, 2025

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -20.32.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 1
Value: $783
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 3
Value: $2K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 1
Value: $786
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 2
Value: $2K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 1
Value: $788
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 1
Value: $785
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 5
Value: $4K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 57
Value: $44.3K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 12
Value: $9K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 5
Value: $4K
Feb 09, 2026
Buy
Common Stock
M-Exempt
Pitofsky Jason
SVP Controller
Officer 1 000
Value: $492.0K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 521
Value: $404.5K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 563
Value: $438.2K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 75
Value: $58.5K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 26
Value: $20.3K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 37
Value: $29.0K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 144
Value: $112.8K
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 1
Value: $785
Feb 09, 2026
Sell
Common Stock
S-Sale
Pitofsky Jason
SVP Controller
Officer 53
Value: $41.6K
Feb 09, 2026
Buy
Non-Qualified Stock Option (right to buy)
M-Exempt
Pitofsky Jason
SVP Controller
Officer 1 000
Value: $492.0K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 1
Value: $776
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 10
Value: $8K
Feb 09, 2026
Sell
Common Stock
S-Sale
Ryan Arthur F
Director
Director 1
Value: $780
Jan 07, 2026
Sell
Common Stock
S-Sale
Bassler Bonnie L
Director
Director 1 500
Value: $1.20M
Jan 07, 2026
Buy
Common Stock
M-Exempt
Bassler Bonnie L
Director
Director 1 500
Value: $561.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT REGENERON PHARMACEUTICALS
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlus...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE